Currax Pharmaceuticals
Manufacturing · United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
United StatesWebsite
www.treximet.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Currax Pharmaceuticals
TREXIMET® may increase your chance of a heart attack or stroke that can lead to death. TREXIMET® contains 2 medicines: sumatriptan and naproxen sodium (a nonsteroidal anti-inflammatory drug [NSAID]). This risk may happen early in treatment and may increase: with longer use of NSAIDs. Avoid taking TREXIMET® after a recent heart attack, unless your healthcare provider tells you to. You may have an increased risk of another heart attack if you take NSAIDs after a recent heart attack. Stop taking TREXIMET® and get emergency help right away if you have any of the following symptoms of a heart attack or stroke: discomfort in the center of your chest that lasts for more than a few minutes, or that goes away and comes back severe tightness, pain, pressure, or heaviness in your chest, throat, neck, or jaw pain or discomfort in your arms, back, neck, jaw, or stomach TREXIMET® is not for people with risk factors for heart disease unless a heart exam is done and shows no problem. You have a higherRead more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Currax Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Currax Pharmaceuticals launches new products
Funding: Get notified immidiatlly once Currax Pharmaceuticals has new funding data
Check if Currax Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Currax Pharmaceuticals recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Currax Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Currax Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Currax Pharmaceuticals is spiking on competitors!
Website visits: Recent activity has been detected on your website
Click to see if Currax Pharmaceuticals had a recent Job posting/layoffs
Recommended Actions
Reach out to Masked Content who joined Currax Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to Currax Pharmaceuticals
Compare insights from companies similar to Currax Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Currax Pharmaceuticals
<$5M
11-50
Private
-
2018
N/A
Company Profile Activity
Activity Insights
Currax Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Currax Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Currax Pharmaceuticals.
Currax Pharmaceuticals Tech Stack
A closer look at the technologies used by Currax Pharmaceuticals
Top Manufacturing Companies
See more top companies
Frequently Asked Questions Regarding Currax Pharmaceuticals
Sign Up For FreeTo access detailed company insights
TREXIMET® may increase your chance of a heart attack or stroke that can lead to death. TREXIMET® contains 2 medicines: sumatriptan and naproxen sodium (a nonsteroidal anti-inflammatory drug [NSAID]). This risk may happen early in treatment and may increase: with longer use of NSAIDs. Avoid taking TREXIMET® after a recent heart attack, unless your h... Read More
